TransMedics Group, Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 401
EBIT TTM (mln): 36
index 0 1 2 3 4 5 6 7 8
Rok finansowy 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 6 8 13 24 26 30 93 242 442
Przychód Δ r/r 0.0% 23.8% 69.4% 81.3% 8.6% 18.0% 208.8% 158.5% 82.7%
Marża brutto 12.3% 27.8% 44.1% 58.7% 64.9% 69.9% 69.8% 63.7% 59.4%
EBIT (mln) -23 -20 -20 -30 -26 -39 -31 0 37
EBIT Δ r/r 0.0% -11.1% -0.9% 46.3% -10.9% 49.4% -20.3% -101.5% 7631.1%
EBIT (%) -370.2% -265.8% -155.5% -125.4% -102.9% -130.3% -33.6% 0.2% 8.5%
Koszty finansowe (mln) 1 1 3 4 4 4 4 11 14
EBITDA (mln) -23 -19 -20 -29 -25 -40 -32 9 70
EBITDA(%) -363.3% -250.5% -151.2% -122.1% -96.5% -133.2% -34.7% 3.6% 15.8%
Podatek (mln) 1 0 0 0 0 0 0 -2 0
Zysk Netto (mln) -24 -21 -24 -34 -29 -44 -36 -25 35
Zysk netto Δ r/r 0.0% -13.5% 14.1% 41.2% -14.3% 53.8% -18.1% -30.9% -241.7%
Zysk netto (%) -387.6% -271.0% -182.5% -142.1% -112.1% -146.1% -38.8% -10.4% 8.0%
EPS -1.66 -1.44 -1.23 -2.36 -1.16 -1.6 -1.23 -0.77 1.07
EPS (rozwodnione) -1.66 -1.44 -1.23 -2.36 -1.16 -1.6 -1.23 -0.77 1.01
Ilośc akcji (mln) 14 14 19 14 25 28 30 33 33
Ważona ilośc akcji (mln) 14 14 19 14 25 28 30 33 35
Waluta USD USD USD USD USD USD USD USD USD